However TGAL may also be raised in DG, heterozygous CG carriers, neonatal liver disease and other rare inherited metabolic disorders, and therefore second‐tier analysis of galactose metabolites and GALT activity is used to increase specificity.15 This evidence concerns the gene GALT and liver disorder.